WeVote

Bill

Bill

HF 318

A bill for an act relating to cost-sharing requirements for supplemental and diagnostic breast examinations.

2025-2026 Regular Session

Iowa bill removes patient cost-sharing for supplemental and diagnostic breast imaging to improve cancer detection accessibility and early treatment outcomes.

Subcommittee recommends passage.
0
WeVote Research Nonpartisan
Bill Summary · HF 318

Legislative bill overview

HF 318 eliminates or reduces out-of-pocket cost-sharing (copayments, coinsurance, deductibles) for supplemental and diagnostic breast examinations in Iowa. The bill ensures these imaging services are covered without financial barriers to patients, aligning with preventive care accessibility standards.

Why is this important

Early detection of breast cancer significantly improves treatment outcomes and survival rates. Removing cost barriers increases the likelihood that women will pursue recommended supplemental screening (such as ultrasounds or MRIs for dense breast tissue), potentially catching cancer at earlier, more treatable stages. This addresses healthcare equity by preventing financial hardship from delaying or avoiding necessary diagnostic imaging.

Potential points of contention

  • Insurance cost impact: Insurers and employers may face increased premium costs if more patients access these services without cost-sharing, potentially raising healthcare expenses system-wide
  • Definition scope: Ambiguity about which specific breast imaging procedures qualify as "supplemental" versus routine could create implementation disputes and coverage inconsistencies
  • Access vs. overutilization: Removing cost barriers might increase unnecessary screening requests, leading to higher healthcare spending without proportional health improvements or raising concerns about patient-initiated overuse

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.